Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 135 results for "Victoza"

Opinion/decision on a Paediatric Investigation Plan (PIP): ...

Place, Canary Wharf, London E14 5EU, United Kingdom . Tel. +44 (0)20 3660 6000 . Fax +44 European Medicines Agency, 2 months ago

15 images for Victoza

Milwaukee Journal Sentinel, 5 days ago
Pharma Letter, 3 months ago
diaTribe, 3 months ago
diaTribe, 3 months ago
diaTribe, 3 months ago
diaTribe, 3 months ago
diaTribe, 3 months ago
diaTribe, 3 months ago
diaTribe, 3 months ago
diaTribe, 3 months ago
Global Information Inc

LEAN trial: Victoza effective in resolving NASH

VIENNA — More overweight patients with nonalcoholic steatohepatitis treated with Victoza injections experienced resolved nonalcoholic steatohepatitis and reduced fibrosis worsening vs. patients who received placebo, according to findings presented ...
 Orthopedics Today3 days ago Nonalcoholic Steatohepatitis: KOL Insight  Global Information Inc1 month ago

liraglutide, Victoza

Pharmacy Author: Omudhome Ogbru, PharmD Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University ...
 MedicineNet.com3 weeks ago liraglutide injection (Saxenda)  MedicineNet.com2 months ago

Novo Nordisk's Victoza Tops List of Drug Payments to Physicians

Novo Nordisk paid more than $9 million to physicians for promotion of its diabetes drug Victoza in the last five months of 2013, topping the list of drugs that were responsible for the most physician payments during the first reporting period ...
 FDA News1 month ago -Novo Nordisk has positive trial results for oral diabetes drug, shares jump  Sharenet2 months ago Novo Nordisk (NVO) Stock Jumps On Positive Phase II Results For Oral Diabetes Drug  Bidness Etc2 months ago CORRECTED-UPDATE 1-Novo Nordisk has positive trial results for oral diabetes drug, shares jump  Reuters2 months ago

Novo Nordisk increased operating profit in local currencies by 13% in 2014

Sales growth of 8% in local currencies driven by growth in sales ofLevemir® and Victoza®
 Andhra News2 months ago

Orexigen Has Contrave Recapturing Early-Year Form, But Needs European Launch

Contrave blasted past 12,000 prescriptions and 32% share in a little over half a year on the market. Starting this week, however, Orexigen is welcoming extra manpower to promote weight loss drugs. Orexigen's share of product sales isn't enough ...
 Seeking Alpha1 day ago

Investigational Diabetes Drug Eyed for Steatohepatitis (CME/CE)

Action Points Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal. Note that this randomized trial of a ...
 MedPage Today1 day ago Diabetes Drug Makes NASH Vanish in Some Patients (CME/CE)  MedPage Today2 days ago
Bariatric News

Liraglutide improves risk factors for heart disease

Liraglutide, in combination with diet and exercise, led to a significant reduction in weight and improved a number of cardiovascular risk factors, including high blood pressure and high cholesterol, according to the results from a multi-centre study ...
 Bariatric News2 days ago Liraglutide improves weight, HbA1c in overweight/obese adults with type 2 diabetes  Orthopedics Today1 month ago

Obesity Drug Seeks U.S. Niche

Business Published on April 23rd, 2015 | by Novo Nordisk is betting its new obestiy drug Saxenda is going to find a comfortable niche in the crowded weight-loss drug market in the U.S., in part because of the company's existing relationships ...
 Nordic Life Science2 days ago What Novo Nordisk's Entry Into The Obesity Space Means To The Sector  Seeking Alpha3 days ago Novo Nordisk (NVO) Launches Obesity Drug In US At Over $1,000 Per Month  Mr Top Step3 days ago Eyeing big niche in obesity, Novo rolls out Saxenda at $1,000 per month  FiercePharma3 days ago

Two Diabetes Drugs May Ease Fatty Liver Disease

VIENNA, Austria — Two diabetes drugs, one approved and one investigational, show promise in treating fatty liver disease, according to new research presented here at the European Association for the Study of the Liver (EASL) International Liver ...
 Dermatology Online Journal2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Victoza
Get updated on latest news & your favorite topics right in your inbox!
More     Less